Lv1
19 积分 2020-06-28 加入
An intrinsically hydrophilic linker enables a stable, high-DAR exatecan-based HER2 ADC with potent antitumor activity
21小时前
已完结
Generation of DAR1 Antibody-Drug Conjugates for Ultrapotent Payloads Using Tailored GlycoConnect Technology
5天前
已完结
An intrinsically hydrophilic linker enables a stable, high-DAR exatecan-based HER2 ADC with potent antitumor activity
6天前
已完结
Homocamptothecin Payloads with Enhanced Potency for Antibody-Drug Conjugates
6天前
已完结
Antibody–Drug Conjugates Synergize with Agonist Anti-CD137 Monoclonal Antibodies in Solid Tumors
6天前
已完结
Development of a Homogeneous Trastuzumab-Triptolide Conjugate for Targeted Therapy of HER2-Overexpressing Ovarian Cancer
6天前
已完结
Developing selective PI3K degraders to modulate both kinase and non-kinase functions
2个月前
已关闭
A high affinity pan-PI3K binding module supports selective targeted protein degradation of PI3Kα
2个月前
已完结
Discovery of the First Potent PI3K/mTOR Dual-Targeting PROTAC Degrader for Efficient Modulation of the PI3K/AKT/mTOR Pathway
2个月前
已完结
Modular in vivo antibody–ADC click to reverse drug resistance in tumours
3个月前
已完结
皖公网安备34019202002308
